Current Legal Status

Active Legislation — $6M Hospital Pilot Live

Psilocybin remains Schedule I under New Jersey law for personal possession. However, the state's $6M Hospital Pilot Program (launched January 2026) operates inside licensed New Jersey hospitals under research and IRB protocols, providing supervised psilocybin sessions for treatment-resistant depression and PTSD within a clinical-trial framework. Personal-possession decriminalization and a broader therapeutic services act remain in committee.

Key Legislation

A5765 (2024) proposed decriminalizing personal psilocybin possession — passed Assembly committee. S3630 (2025) therapeutic services act introduced with bipartisan support; in Senate Health Committee. Most consequential: the FY2026 budget allocation establishing the $6M Hospital Pilot, signed in late 2025 and operational since January 2026.

Therapeutic Programs

$6M Hospital Pilot Program — launched January 2026. Supervised psilocybin sessions inside participating New Jersey hospitals, structured as IRB-approved clinical research with priority enrollment for treatment-resistant depression and PTSD patients. The pilot is the most ambitious state-funded hospital-based psilocybin program in the country and is being closely watched as a template for other states considering hospital-route access rather than freestanding service center models.

Clinical Trials

Rutgers University and Princeton have broad research programs. The $6M Hospital Pilot is itself the largest active enrollment opportunity in the state. Check ClinicalTrials.gov for New Jersey area enrolling psilocybin studies.

Advocacy Organizations

New Jersey Psychedelic Society, Healing Advocacy Fund, MAPS.

Related Resources

Societies & Organizations in New Jersey

See how New Jersey compares to neighboring states and find therapy options for residents: